Neostigmine methylsulfate
These highlights do not include all the information needed to use NEOSTIGMINE METHYLSULFATE INJECTION safely and effectively. See full prescribing information for NEOSTIGMINE METHYLSULFATE INJECTION. NEOSTIGMINE METHYLSULFATE Injection, for intravenous use Initial U.S. Approval: 1939
4eab6184-1771-4c15-a127-4eb3e47affc2
HUMAN PRESCRIPTION DRUG LABEL
Feb 17, 2021
Gland Pharma Limited
DUNS: 918601238
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Neostigmine methylsulfate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
Neostigmine methylsulfate
Product Details
FDA regulatory identification and product classification information